These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Effects of intratumoral inflammatory process on 18F-FDG uptake: pathologic and comparative study with 18F-fluoro-α-methyltyrosine PET/CT in oral squamous cell carcinoma. Kim M; Achmad A; Higuchi T; Arisaka Y; Yokoo H; Yokoo S; Tsushima Y J Nucl Med; 2015 Jan; 56(1):16-21. PubMed ID: 25476535 [TBL] [Abstract][Full Text] [Related]
3. Prognostic value of metabolic tumor volume of pretreatment Kumasaka S; Nakajima T; Arisaka Y; Tokue A; Achmad A; Fukushima Y; Shimizu K; Kaira K; Higuchi T; Tsushima Y BMC Med Imaging; 2018 Nov; 18(1):46. PubMed ID: 30477476 [TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of standardized uptake value and metabolic tumour volume on ¹⁸F-FDG PET/CT in oropharyngeal squamous cell carcinoma. Kim JW; Oh JS; Roh JL; Kim JS; Choi SH; Nam SY; Kim SY Eur J Nucl Med Mol Imaging; 2015 Aug; 42(9):1353-61. PubMed ID: 26067088 [TBL] [Abstract][Full Text] [Related]
5. ¹⁸F-FAMT uptake correlates with tumor proliferative activity in oral squamous cell carcinoma: comparative study with ¹⁸F-FDG PET and immunohistochemistry. Miyashita G; Higuchi T; Oriuchi N; Arisaka Y; Hanaoka H; Tominaga H; Morita S; Miyakubo M; Ishikita T; Nakasone Y; Negishi A; Yokoo S; Endo K Ann Nucl Med; 2010 Oct; 24(8):579-84. PubMed ID: 20652456 [TBL] [Abstract][Full Text] [Related]
6. Hypoxic volume evaluated by Sato J; Kitagawa Y; Watanabe S; Asaka T; Ohga N; Hirata K; Shiga T; Satoh A; Tamaki N Int J Oral Maxillofac Surg; 2018 May; 47(5):553-560. PubMed ID: 29030021 [TBL] [Abstract][Full Text] [Related]
7. Diagnostic usefulness of ¹⁸F-FAMT PET and L-type amino acid transporter 1 (LAT1) expression in oral squamous cell carcinoma. Nobusawa A; Kim M; Kaira K; Miyashita G; Negishi A; Oriuchi N; Higuchi T; Tsushima Y; Kanai Y; Yokoo S; Oyama T Eur J Nucl Med Mol Imaging; 2013 Oct; 40(11):1692-700. PubMed ID: 23801167 [TBL] [Abstract][Full Text] [Related]
8. Lymph node standardized uptake values at pre-treatment Jeong Y; Baek S; Park JW; Joo JH; Kim JS; Lee SW Br J Radiol; 2017 Mar; 90(1071):20160239. PubMed ID: 28008776 [TBL] [Abstract][Full Text] [Related]
9. Clinical significance of ¹⁸F-α-methyl tyrosine PET/CT for the detection of bone marrow invasion in patients with oral squamous cell carcinoma: comparison with ¹⁸F-FDG PET/CT and MRI. Kim M; Higuchi T; Arisaka Y; Achmad A; Tokue A; Tominaga H; Miyashita G; Miyazaki H; Negishi A; Yokoo S; Tsushima Y Ann Nucl Med; 2013 Jun; 27(5):423-30. PubMed ID: 23436243 [TBL] [Abstract][Full Text] [Related]
10. Prognostic value of metabolic tumor volume measured by 18F-fluorodeoxyglucose positron emission tomography in patients with esophageal carcinoma. Hyun SH; Choi JY; Shim YM; Kim K; Lee SJ; Cho YS; Lee JY; Lee KH; Kim BT Ann Surg Oncol; 2010 Jan; 17(1):115-22. PubMed ID: 19826877 [TBL] [Abstract][Full Text] [Related]
11. 18F-FDG PET/CT metabolic tumor volume and total lesion glycolysis predict outcome in oropharyngeal squamous cell carcinoma. Lim R; Eaton A; Lee NY; Setton J; Ohri N; Rao S; Wong R; Fury M; Schöder H J Nucl Med; 2012 Oct; 53(10):1506-13. PubMed ID: 22895812 [TBL] [Abstract][Full Text] [Related]
12. The Volume-metabolic Combined Parameters from (18)F-FDG PET/CT May Help Predict the Outcomes of Cervical Carcinoma. Sun Y; Lu P; Yu L Acad Radiol; 2016 May; 23(5):605-10. PubMed ID: 26853968 [TBL] [Abstract][Full Text] [Related]
13. Nodal parameters of FDG PET/CT performed during radiotherapy for locally advanced mucosal primary head and neck squamous cell carcinoma can predict treatment outcomes: SUVmean and response rate are useful imaging biomarkers. Lin P; Min M; Lee M; Holloway L; Forstner D; Bray V; Fowler A Eur J Nucl Med Mol Imaging; 2017 May; 44(5):801-811. PubMed ID: 28004135 [TBL] [Abstract][Full Text] [Related]
14. Metabolic tumor volume and total lesion glycolysis predict tumor progression and survival after salvage surgery for recurrent oral cavity squamous cell carcinoma. Choi WR; Oh JS; Roh JL; Kim JS; Oh I; Choi SH; Nam SY; Kim SY Head Neck; 2019 Jun; 41(6):1846-1853. PubMed ID: 30675738 [TBL] [Abstract][Full Text] [Related]
15. Prognostic value of Lee JR; Almuhaimid TM; Roh JL; Oh JS; Kim SJ; Kim JS; Choi SH; Nam SY; Kim SY J Surg Oncol; 2018 Sep; 118(4):644-650. PubMed ID: 30132891 [TBL] [Abstract][Full Text] [Related]
16. Influence of volumetric 4'-[methyl- Hoshikawa H; Mori T; Maeda Y; Takahashi S; Ouchi Y; Yamamoto Y; Nishiyama Y Ann Nucl Med; 2017 Jan; 31(1):63-70. PubMed ID: 27679399 [TBL] [Abstract][Full Text] [Related]
17. Whole-Body Metabolic Tumor Volume, as Determined by (18)F-FDG PET/CT, as a Prognostic Factor of Outcome for Patients With Breast Cancer Who Have Distant Metastasis. Son SH; Lee SW; Jeong SY; Song BI; Chae YS; Ahn BC; Lee J AJR Am J Roentgenol; 2015 Oct; 205(4):878-85. PubMed ID: 26204115 [TBL] [Abstract][Full Text] [Related]
18. Prognostic value of maximum standardized uptake value measured by pretreatment 18F-FDG PET/CT in locally advanced head and neck squamous cell carcinoma. Cacicedo J; Fernandez I; Del Hoyo O; Navarro A; Gomez-Iturriaga A; Pijoan JI; Martinez-Indart L; Escudero J; Gomez-Suarez J; de Zarate RO; Perez JF; Bilbao P; Rades D Clin Transl Oncol; 2017 Nov; 19(11):1337-1349. PubMed ID: 28540535 [TBL] [Abstract][Full Text] [Related]
19. Prospective evaluation of qualitative and quantitative ¹⁸F-FDG PET-CT parameters for predicting survival in recurrent carcinoma of the cervix. Maharjan S; Sharma P; Patel CD; Sharma DN; Dhull VS; Jain SK; Thulkar S; Malhotra A; Kumar R Nucl Med Commun; 2013 Aug; 34(8):741-8. PubMed ID: 23676840 [TBL] [Abstract][Full Text] [Related]
20. Prediction of distant metastasis and survival in adenoid cystic carcinoma using quantitative Lim WS; Oh JS; Roh JL; Kim JS; Kim SJ; Choi SH; Nam SY; Kim SY Oral Oncol; 2018 Feb; 77():98-104. PubMed ID: 29362133 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]